Cargando…
Brachytherapy for oligometastatic prostate cancer to the penis
The origin of penile metastases is in 70% of cases from primary pelvic cancers (genitourinary and recto-sigmoid primary tumors). The prognosis is poor and it is often associated with synchronous bone metastases at the time of diagnosis. We present the case of a 61-year-old patient who developed a pe...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565627/ https://www.ncbi.nlm.nih.gov/pubmed/34759985 http://dx.doi.org/10.5114/jcb.2021.109754 |
_version_ | 1784593853565632512 |
---|---|
author | Martz, Nicolas Benziane-Ouaritini, Nicolas Gautier, Mathieu Brenot-Rossi, Isabelle Montagne, Lucile Salem, Naji Bodokh, Yohan Hannoun-Levi, Jean-Michel |
author_facet | Martz, Nicolas Benziane-Ouaritini, Nicolas Gautier, Mathieu Brenot-Rossi, Isabelle Montagne, Lucile Salem, Naji Bodokh, Yohan Hannoun-Levi, Jean-Michel |
author_sort | Martz, Nicolas |
collection | PubMed |
description | The origin of penile metastases is in 70% of cases from primary pelvic cancers (genitourinary and recto-sigmoid primary tumors). The prognosis is poor and it is often associated with synchronous bone metastases at the time of diagnosis. We present the case of a 61-year-old patient who developed a penile induration 7 years after radical prostatectomy followed by adjuvant external beam radiation therapy for high-risk prostatic adenocarcinoma. Biopsies confirmed the metastatic localization and a detailed assessment failed to find any further remote lesions. Faced with this penile oligometastatic prostate cancer, we proposed an ablative treatment based on interstitial multi-catheter high-dose rate brachytherapy. At the six-month follow-up, clinical examination and (68)Ga-PSMA-11-PET confirmed a complete response of the penile tumor without new lesion at a distance. |
format | Online Article Text |
id | pubmed-8565627 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-85656272021-11-09 Brachytherapy for oligometastatic prostate cancer to the penis Martz, Nicolas Benziane-Ouaritini, Nicolas Gautier, Mathieu Brenot-Rossi, Isabelle Montagne, Lucile Salem, Naji Bodokh, Yohan Hannoun-Levi, Jean-Michel J Contemp Brachytherapy Case Report The origin of penile metastases is in 70% of cases from primary pelvic cancers (genitourinary and recto-sigmoid primary tumors). The prognosis is poor and it is often associated with synchronous bone metastases at the time of diagnosis. We present the case of a 61-year-old patient who developed a penile induration 7 years after radical prostatectomy followed by adjuvant external beam radiation therapy for high-risk prostatic adenocarcinoma. Biopsies confirmed the metastatic localization and a detailed assessment failed to find any further remote lesions. Faced with this penile oligometastatic prostate cancer, we proposed an ablative treatment based on interstitial multi-catheter high-dose rate brachytherapy. At the six-month follow-up, clinical examination and (68)Ga-PSMA-11-PET confirmed a complete response of the penile tumor without new lesion at a distance. Termedia Publishing House 2021-10-06 2021-10 /pmc/articles/PMC8565627/ /pubmed/34759985 http://dx.doi.org/10.5114/jcb.2021.109754 Text en Copyright © 2021 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) ) |
spellingShingle | Case Report Martz, Nicolas Benziane-Ouaritini, Nicolas Gautier, Mathieu Brenot-Rossi, Isabelle Montagne, Lucile Salem, Naji Bodokh, Yohan Hannoun-Levi, Jean-Michel Brachytherapy for oligometastatic prostate cancer to the penis |
title | Brachytherapy for oligometastatic prostate cancer to the penis |
title_full | Brachytherapy for oligometastatic prostate cancer to the penis |
title_fullStr | Brachytherapy for oligometastatic prostate cancer to the penis |
title_full_unstemmed | Brachytherapy for oligometastatic prostate cancer to the penis |
title_short | Brachytherapy for oligometastatic prostate cancer to the penis |
title_sort | brachytherapy for oligometastatic prostate cancer to the penis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565627/ https://www.ncbi.nlm.nih.gov/pubmed/34759985 http://dx.doi.org/10.5114/jcb.2021.109754 |
work_keys_str_mv | AT martznicolas brachytherapyforoligometastaticprostatecancertothepenis AT benzianeouaritininicolas brachytherapyforoligometastaticprostatecancertothepenis AT gautiermathieu brachytherapyforoligometastaticprostatecancertothepenis AT brenotrossiisabelle brachytherapyforoligometastaticprostatecancertothepenis AT montagnelucile brachytherapyforoligometastaticprostatecancertothepenis AT salemnaji brachytherapyforoligometastaticprostatecancertothepenis AT bodokhyohan brachytherapyforoligometastaticprostatecancertothepenis AT hannounlevijeanmichel brachytherapyforoligometastaticprostatecancertothepenis |